- Home
- BCAT vs PAHC Comparison
BCAT vs PAHC Comparison
Compare BCAT & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAT
- PAHC
- Stock Information
- Founded
- BCAT 2020
- PAHC 1946
- Country
- BCAT United States
- PAHC United States
- Employees
- BCAT N/A
- PAHC N/A
- Industry
- BCAT Finance/Investors Services
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- BCAT Finance
- PAHC Health Care
- Exchange
- BCAT Nasdaq
- PAHC Nasdaq
- Market Cap
- BCAT 1.5B
- PAHC 1.2B
- IPO Year
- BCAT N/A
- PAHC 2014
- Fundamental
- Price
- BCAT $14.76
- PAHC $40.54
- Analyst Decision
- BCAT
- PAHC Hold
- Analyst Count
- BCAT 0
- PAHC 4
- Target Price
- BCAT N/A
- PAHC $27.50
- AVG Volume (30 Days)
- BCAT 308.8K
- PAHC 389.0K
- Earning Date
- BCAT 01-01-0001
- PAHC 11-05-2025
- Dividend Yield
- BCAT 9.38%
- PAHC 1.24%
- EPS Growth
- BCAT N/A
- PAHC 1895.04
- EPS
- BCAT 1.43
- PAHC 1.19
- Revenue
- BCAT N/A
- PAHC $1,296,215,000.00
- Revenue This Year
- BCAT N/A
- PAHC $13.56
- Revenue Next Year
- BCAT N/A
- PAHC $3.06
- P/E Ratio
- BCAT $11.41
- PAHC $32.42
- Revenue Growth
- BCAT N/A
- PAHC 27.37
- 52 Week Low
- BCAT $13.67
- PAHC $16.16
- 52 Week High
- BCAT $16.38
- PAHC $41.57
- Technical
- Relative Strength Index (RSI)
- BCAT 41.71
- PAHC 68.54
- Support Level
- BCAT $14.64
- PAHC $38.43
- Resistance Level
- BCAT $15.29
- PAHC $41.57
- Average True Range (ATR)
- BCAT 0.12
- PAHC 1.43
- MACD
- BCAT -0.04
- PAHC -0.16
- Stochastic Oscillator
- BCAT 19.02
- PAHC 85.12
About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.